A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. (Q53357603)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. |
scientific article |
Statements
A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. (English)
Clive G Ballard
Alan Thomas
Jane Fossey
Lesley Lee
Robin Jacoby
Marisa M Lana
Carol Bannister
Rupert McShane
Alan Swann
Ed Juszczak
1 January 2004
65
1
114-119